Home > Publications > METRIC Study Group. Improved survival with MEK inhibition in BRAF-mutated melanoma.
Centenary Institute - Medical Research
Centenary Institute - Medical Research

METRIC Study Group. Improved survival with MEK inhibition in BRAF-mutated melanoma.

Flaherty, K.T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L.V., Hassel, J.C. Rutkowski, P., Mohr, P., Dummer, R., Trefzer, U., Larkin, J.M., Utikal, J., Dreno, B., Nyakas, M., Middleton, M.R., Becker, J.C., Casey, M., Sherman, L.J., Wu, F.S., Ouellet, D., Martin, A.M., Patel, K., Schadendorf., D.

New England Journal of Medicine Jul 12;367(2):107-14.

Date: 0

//